期刊文献+

一种小型复方雷帕霉素栓剂的制备及其体外质量评价 被引量:1

Preparation and in vitro quality evaluation of a small type of compound rapamycin suppositories
下载PDF
导出
摘要 目的:制备一种适用于大型动物腹部器官移植术后的免疫抑制药物栓剂,并对其进行质量评价。方法:以雷帕霉素(rapamycin)和他克莫司(tacrolmius)为原料药,聚乙二醇2000和聚乙二醇4000为主要基质,采用热熔法结合定量注模成型工艺制备复方栓剂,并对其外观、重量差异、融变时限、药物含量进行评价。结果:复方雷帕霉素栓剂外观呈白色半透明状,室温下硬度较好,长度短,重量差异、融变时限和药物含量均符合栓剂要求。结论:本方法制备的复方雷帕霉素栓剂质量符合栓剂要求,为该药物的新药开发奠定了基础。 Objective:To develop a small type of suppository of immunosuppressive agents to suit for large animals after abdominal organ transplantation, and carry out it’s quality evaluation. Methods:Rapamycin and ta-crolimusas were chosed as active pharmaceutical ingredients, and polyethylene glycol 2000, polyethylene glycol 4000 were used as substrate. Melting followed with a quantitative injection molding process was used to prepare the small type of compound suppository. The appearance, weight difference, melting time and drug content of the suppository were evaluated. Results:The compound rapamycin suppository was translucent, white, and had good hardness at room temperature. It’s short, and the weight variation, melting time and drug content were con-formed to the requirements of the suppository. Conclusion:The compound rapamycin suppository prepared by this method conforms to the quality of suppository, which makes a good foundation for the development of the new drug.
出处 《温州医学院学报》 CAS 2015年第4期278-280,共3页 Journal of Wenzhou Medical College
基金 义乌市科研计划项目(13-3-28)
关键词 复方 雷帕霉素 他克莫司 栓剂 质量评价 compound rapamycin tacrolimus suppositories quality evaluation
  • 相关文献

参考文献9

二级参考文献25

  • 1马朝来,张同琳,王坤,孙和新.FK506预处理下骨髓移植诱导同种异体小鼠皮肤移植耐受的实验研究[J].中国微创外科杂志,2004,4(5):438-440. 被引量:10
  • 2焦海春,肖建华(审校者).FOXP3的研究进展[J].国际免疫学杂志,2007,30(2):91-95. 被引量:5
  • 3Slavik JM,Lim DG,Burakoff SJ,et al.Uncoupling p70(s6) kinase activation and proliferation;rapamycin-resistant proliferation of human CD8(+)T lymphocytes.J Immunol[J].2001,166(5):3201-3209.
  • 4Kitagawa H,Hotta Y,Fujiki K,et al.Cloning and high expression of rabbit FKBP25 in cornea.Jpn J Ophthalmol[J].1996,40(2):133-141.
  • 5Mohaupt MG,Vogt B,Freg FJ.Sirolimu sassociated eyelid edema in kidney transplant recipients.Transplantation[J] ,2001,72 (1):162-164.
  • 6Bertelmann E,Pleyer U.Immunomodulatory therapy in ophthalmo-1 ogy-is there a place for topical application? Ophthalmology[J] ,2003,100(12):1036-1044.
  • 7中国药典委员会.中国药典第二部[S].2000(附录):332.
  • 8Chang K,Sehgal SN.Pharmacology of rapamycin:a new immunosuppressive agent.Br J Rheumatol[J].1991,30:62-65.
  • 9D.W.Holt,D.A.McKeown,T.D.Lee,et al.The Relative Proportions of Sirolimus Metabolites in Blood Using HPLC With MassSpectrometric Detection.Transplantation Proceedings[J] ,2004,36:3223-3225.
  • 10Sehgal SN.Rapamune (RAPA,rapamycin,sirolimus):mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression[J].Clin Biochem,2006,39(5):484-489.

共引文献62

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部